Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Because the drug acts on gut hormone receptors and slows gastric emptying, the most commonly reported adverse effects in Phase 2 trials include: Nausea (particularly during dose escalation) Vomiting Diarrhoea Constipation Decreased appetite These effects were generally described as mild to moderate in severity and tended to diminish over time
Theyre often prescribed for type 2 diabetes and weight loss
Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomised controlled trials
This is super important because high blood sugar (glucose) levels over a long period can lead to serious health problems like diabetes
